<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="mrm30522" xml:lang="en" article-type="other" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Magn Reson Med</journal-id><journal-id journal-id-type="iso-abbrev">Magn Reson Med</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">MRM</journal-id><journal-title-group><journal-title>Magnetic Resonance in Medicine</journal-title></journal-title-group><issn pub-type="ppub">0740-3194</issn><issn pub-type="epub">1522-2594</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12202720</article-id><article-id pub-id-type="pmcid-ver">PMC12202720.1</article-id><article-id pub-id-type="pmcaid">12202720</article-id><article-id pub-id-type="pmcaiid">12202720</article-id><article-id pub-id-type="pmid">40189753</article-id><article-id pub-id-type="doi">10.1002/mrm.30522</article-id><article-id pub-id-type="publisher-id">MRM30522</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Technical Note</subject></subj-group><subj-group subj-group-type="heading"><subject>Preclinical and Clinical Imaging</subject></subj-group></article-categories><title-group><article-title>Time&#8208;course manganese chloride biodistribution and manganese&#8208;induced <styled-content style="fixed-case" toggle="no">MRI</styled-content> contrast in mouse organs</article-title><alt-title alt-title-type="left-running-head">ZHUANG et al.</alt-title></title-group><contrib-group><contrib id="mrm30522-cr-0001" contrib-type="author"><name name-style="western"><surname>Zhuang</surname><given-names initials="K">Keyu</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-6282-1357</contrib-id><xref rid="mrm30522-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mrm30522-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mrm30522-cr-0002" contrib-type="author"><name name-style="western"><surname>Vollett</surname><given-names initials="KDW">Kyle D. W.</given-names></name><xref rid="mrm30522-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mrm30522-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mrm30522-cr-0003" contrib-type="author"><name name-style="western"><surname>Hou</surname><given-names initials="M">Minbo</given-names></name><xref rid="mrm30522-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="mrm30522-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="mrm30522-cr-0004" contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="Y">Yan</given-names></name><xref rid="mrm30522-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="mrm30522-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="mrm30522-cr-0005" contrib-type="author" corresp="yes"><name name-style="western"><surname>Cheng</surname><given-names initials="HLM">Hai&#8208;Ling Margaret</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0733-9512</contrib-id><xref rid="mrm30522-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mrm30522-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="mrm30522-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><address><email>hailing.cheng@utoronto.ca</email></address></contrib></contrib-group><aff id="mrm30522-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Institute of Biomedical Engineering</named-content>
<institution>University of Toronto</institution>
<city>Toronto</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="mrm30522-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Translational Biology &amp; Engineering Program</named-content>
<institution>Ted Rogers Centre for Heart Research</institution>
<city>Toronto</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="mrm30522-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Shanghai InnoStar Bio&#8208;tech Co., Ltd.</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff><aff id="mrm30522-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>China State Institute of Pharmaceutical Industry</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff><aff id="mrm30522-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">The Edward S. Rogers Sr. Department of Electrical and Computer Engineering</named-content>
<institution>University of Toronto</institution>
<city>Toronto</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Hai&#8208;Ling Margaret Cheng, 661 University Avenue, Toronto, Ontario, Canada.<break/>
Email: <email>hailing.cheng@utoronto.ca</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><volume>94</volume><issue seq="270">3</issue><issue-id pub-id-type="pmc-issue-id">491639</issue-id><issue-id pub-id-type="doi">10.1002/mrm.v94.3</issue-id><fpage>1227</fpage><lpage>1236</lpage><history><date date-type="rev-recd"><day>19</day><month>3</month><year>2025</year></date><date date-type="received"><day>13</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-28 07:25:26.703"><day>28</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Magnetic Resonance in Medicine</italic> published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="MRM-94-1227.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:MRM-94-1227.pdf"/><abstract><title>Abstract</title><sec id="mrm30522-sec-0001"><title>Purpose</title><p>To optimize manganese&#8208;enhanced MRI (MEMRI) in mice by profiling the time&#8208;course biodistribution and associated T<sub>1</sub> contrast enhancement of MnCl<sub>2</sub> injected subcutaneously to avoid abrupt spikes in blood manganese levels.</p></sec><sec id="mrm30522-sec-0002"><title>Methods</title><p>Manganese (Mn) biodistribution and Mn&#8208;induced T<sub>1</sub> contrast in healthy female adult CD&#8208;1 mice were investigated at two doses (0.2 and 0.4&#8201;mmol/kg) and 2, 6, and 24&#8201;h following injection. T<sub>1</sub>&#8208;weighted MRI and T<sub>1</sub> mapping were performed at 3&#8201;T. The heart, liver, kidneys, leg skeletal muscle, lungs, spleen, and blood were collected and quantified for Mn content using inductively coupled plasma atomic emission spectroscopy. Toxicity was assessed on hematoxylin and eosin histological sections of the heart, liver, kidneys, lungs, and spleen.</p></sec><sec id="mrm30522-sec-0003"><title>Results</title><p>An injection dose of 0.2&#8201;mmol/kg produced significant T<sub>1</sub> enhancement in the heart, liver, and kidneys, reaching peak enhancement at 2&#8201;h following injection. Doubling the dose did not produce further T<sub>1</sub> enhancement in the heart, liver, nor kidneys. Skeletal muscle reached peak enhancement at 24&#8201;h and required an injection dose of 0.4&#8201;mmol/kg. Inductively coupled plasma atomic emission spectroscopy&#8211;measured tissue&#8208;level Mn content corroborated MRI results and revealed peak Mn concentration also at 2&#8201;h following injection in the spleen, lungs, and blood. No organ toxicity was observed at either dose on histology.</p></sec><sec id="mrm30522-sec-0004"><title>Conclusion</title><p>The subcutaneous injection route provided substantial T<sub>1</sub> contrast enhancement in all tissues investigated, without toxicity at the maximum dose of 0.4&#8201;mmol/kg tested. However, the injection dose and optimal postinjection imaging interval must be tailored to the organ of interest.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mrm30522-kwd-0001">heart</kwd><kwd id="mrm30522-kwd-0002">kidneys</kwd><kwd id="mrm30522-kwd-0003">liver</kwd><kwd id="mrm30522-kwd-0004">manganese biodistribution</kwd><kwd id="mrm30522-kwd-0005">skeletal muscle</kwd><kwd id="mrm30522-kwd-0006">toxicity</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>New Frontiers in Research Fund</funding-source><award-id>#NFRFE&#8208;2020&#8208;00509</award-id></award-group><award-group id="funding-0002"><funding-source>Dean's Spark Professorship</funding-source></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>Canada Foundation for Innovation
</institution><institution-id institution-id-type="doi">10.13039/501100000196</institution-id></institution-wrap></funding-source><award-id>34038</award-id></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>Natural Sciences and Engineering Research Council of Canada
</institution><institution-id institution-id-type="doi">10.13039/501100000038</institution-id></institution-wrap></funding-source><award-id>RGPIN&#8208;2019&#8208;06137</award-id></award-group><award-group id="funding-0005"><funding-source>Canadian First Research Excellence Fund</funding-source><award-id>#MbDPEFR1&#8208;2021&#8208;04</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="0"/><page-count count="10"/><word-count count="6000"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.7 mode:remove_FC converted:26.06.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="mrm30522-cit-1001"><string-name name-style="western"><surname>Zhuang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Vollett</surname><given-names>KDW</given-names></string-name>, <string-name name-style="western"><surname>Hou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>H&#8208;LM</given-names></string-name>. <article-title>Time&#8208;course manganese chloride biodistribution and manganese&#8208;induced <styled-content style="fixed-case" toggle="no">MRI</styled-content> contrast in mouse organs</article-title>. <source>Magn Reson Med</source>. <year>2025</year>;<volume>94</volume>:<fpage>1227</fpage>&#8208;<lpage>1236</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mrm.30522</pub-id><pub-id pub-id-type="pmcid">PMC12202720</pub-id><pub-id pub-id-type="pmid">40189753</pub-id></mixed-citation>
</p></notes></front><body id="mrm30522-body-0001"><sec id="mrm30522-sec-0005"><label>1</label><title>INTRODUCTION</title><p>Manganese(II) (Mn) is a paramagnetic ion capable of enhancing the contrast of anatomical structures on T<sub>1</sub>&#8208;weighted MRI,<xref rid="mrm30522-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="mrm30522-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> similar to widely deployed gadolinium(III) (Gd)&#8211;based contrast agents. Unlike Gd, which must be chelated for safety, Mn is an endogenous and essential trace mineral involved in regulating biological processes and metabolic pathways.<xref rid="mrm30522-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> For this reason, Mn is significantly less toxic than Gd and can be administered at low doses in its ionic form.<xref rid="mrm30522-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> As an ion&#8212;more specifically, a calcium ion analog&#8212;Mn can cross the cell membrane, such as via voltage&#8208;dependent calcium (Ca<sup>2+</sup>) channels,<xref rid="mrm30522-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> to provide not only anatomical but also functional information on MRI. For over 40&#8201;years, manganese&#8208;enhanced MRI (MEMRI) has been exploited extensively in studying brain structure,<xref rid="mrm30522-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="mrm30522-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> neural activity,<xref rid="mrm30522-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="mrm30522-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> and myocardial viability.<xref rid="mrm30522-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="mrm30522-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> More recently, MEMRI demonstrated the ability to detect and characterize tumors where Gd&#8208;enhanced MRI could not,<xref rid="mrm30522-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="mrm30522-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="mrm30522-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> possibly revealing Ca<sup>2+</sup>&#8208;related mechanisms in proliferating cancer cells.<xref rid="mrm30522-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> MEMRI has also been shown effective in in vivo tracking of genetically engineered human stem cells.<xref rid="mrm30522-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="mrm30522-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Despite the value and potential of MEMRI, however, its exploration beyond the brain and heart is much more limited, and guidelines on Mn administration for body MEMRI are scant.</p><p>Exogenous Mn is typically administered by injecting or ingesting a MnCl<sub>2</sub> solution. To ensure safety, the dose of Mn must be carefully controlled, as overexposure to Mn can induce acute and chronic toxicity, including cardiovascular toxicity, neurodegenerative disorders, and hepatotoxicity.<xref rid="mrm30522-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="mrm30522-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="mrm30522-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> The administration route must also be factored into safety considerations. For instance, most MEMRI studies inject Mn intravenously to achieve rapid distribution, but this is also the riskiest route due to potential acute cardiovascular toxicity from a sudden spike in blood Mn levels.<xref rid="mrm30522-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> Intraperitoneal and subcutaneous injections are less toxic, but the associated slower distribution and accumulation of Mn may result in insufficient contrast if Mn is eliminated from the body more rapidly than its accumulation in tissue. Abundant literature exists in the brain on MEMRI of neuronal architecture and function, contrast efficiency for different injection routes and doses, and in vivo Mn biodistribution.<xref rid="mrm30522-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="mrm30522-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="mrm30522-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="mrm30522-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="mrm30522-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="mrm30522-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="mrm30522-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="mrm30522-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="mrm30522-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Similar studies in the heart can also be found.<xref rid="mrm30522-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="mrm30522-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="mrm30522-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> Outside of the brain and heart, however, very few studies have been carried out. Aside from the handful of reports on whole&#8208;body MnCl<sub>2</sub> distribution and/or contrast enhancement following intravenous<xref rid="mrm30522-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="mrm30522-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="mrm30522-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> and intraperitoneal<xref rid="mrm30522-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="mrm30522-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> injection, little guidance for subcutaneous MnCl<sub>2</sub> injections exist. To the best of our knowledge, there has been no report on time&#8208;course characterization of Mn biodistribution in bodily tissues and MRI contrast efficiency following the safest of administration routes: subcutaneous injection.</p><p>In this study, we investigate organ toxicity and time&#8208;course profile of Mn biodistribution and Mn&#8208;induced MRI contrast in mouse organs after a single subcutaneous injection of MnCl<sub>2</sub>.</p></sec><sec sec-type="methods" id="mrm30522-sec-0006"><label>2</label><title>METHODS</title><sec id="mrm30522-sec-0007"><label>2.1</label><title>Experimental design</title><p>Manganese (Mn) biodistribution and Mn&#8208;induced T<sub>1</sub> contrast in adult female CD&#8208;1 mice after a single subcutaneous injection of MnCl<sub>2</sub> were investigated at three time points following MnCl<sub>2</sub> injection (2, 6, and 24&#8201;h) and two Mn dose levels (0.2 and 0.4&#8201;mmol/kg body weight). Mice were randomly divided into seven groups: 0.2&#8201;mmol/kg Mn dosed mice examined at 2, 6, and 24&#8201;h, 0.4&#8201;mmol/kg Mn dosed mice examined at 2, 6, and 24&#8201;h, and control mice without any treatment (<italic toggle="yes">n</italic>&#8201;=&#8201;3 per group). In parallel, three additional groups of mice (0.2 and 0.4&#8201;mmol/kg Mn dosed mice and control mice without any treatment [<italic toggle="yes">n</italic>&#8201;=&#8201;3 per group]) were used for histopathological assessment 2&#8201;weeks following injection.</p><p>Mice were imaged on a preclinical 3T MR scanner (MR Solutions; Guildford, United Kingdom) using T<sub>1</sub>&#8208;weighted spoiled gradient echo (SPGR) and T<sub>1</sub> mapping both before (baseline) and after MnCl<sub>2</sub> injection (post&#8208;Mn). MnCl<sub>2</sub> solution (100&#8201;mM) was prepared by dissolving MnCl<sub>2</sub>&#183;4H<sub>2</sub>O in Milli&#8208;Q water and filtering through 0.22&#8208;&#956;m membrane. MnCl<sub>2</sub> was injected subcutaneously after baseline MRI scan. Immediately after the post&#8208;Mn MRI scan, mice were euthanized by cardiac puncture under deep anesthesia. Whole blood (0.5&#8201;mL) from each mouse was collected. Heart, liver, kidneys, gastrocnemius muscle, lungs, and spleen tissue were collected, weighed, and digested for Mn quantification using inductively coupled plasma atomic emission spectroscopy (ICP&#8208;AES).</p></sec><sec id="mrm30522-sec-0008"><label>2.2</label><title>Animals</title><p>This study was approved by the University of Toronto's Animal Care Committee (protocol #20012748). All procedures were conducted in accordance with the Canadian Council on Animal Care. Six&#8208;week&#8208;old to 8&#8208;week&#8208;old female CD&#8208;1 (<italic toggle="yes">n</italic>&#8201;=&#8201;30) mice weighing between 20 and 25&#8201;g were purchased (Charles River Laboratories, Canada). Animals acclimatized for 1&#8201;week at the animal facility before the study began.</p></sec><sec id="mrm30522-sec-0009"><label>2.3</label><title>Quantification of Mn content in tissue samples</title><p>Tissue samples were weighed and fully digested by adding 0.25 to 1&#8201;mL of 70% HNO<sub>3</sub> to cover each sample with sonication at 60&#176;C overnight. After digestion, samples were diluted with Milli&#8208;Q water to a final concentration of 2% HNO<sub>3</sub> (8.5 to 35&#8201;mL final volume) and filtered through the 0.22&#8208;&#956;m membrane. Samples were stored at 4&#176;C before analysis on an Optima 7300 DV ICP&#8208;AES spectrometer at the Department of Chemistry, University of Toronto (Toronto, Canada). The Mn concentration in each sample was reported by ICP&#8208;AES in parts per million (ppm) and converted to micromolar (uM). The total Mn content in each sample was calculated using the following equation: micromolar concentration (&#956;M)&#8201;&#215;&#8201;final sample volume (L)/tissue weight (kg).</p></sec><sec id="mrm30522-sec-0010"><label>2.4</label><title>
<styled-content style="fixed-case" toggle="no">MRI</styled-content> acquisition</title><p>MRI acquisition was performed on a preclinical 3T MR scanner (MR Solutions) as previously described.<xref rid="mrm30522-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Mice were induced on 5% isoflurane in 100% oxygen (1.0&#8201;L/min), maintained at 1.5%&#8211;2.0% isoflurane during the entire imaging session, and placed head&#8208;first in a prone position inside a mouse whole&#8208;body coil. Body temperature was maintained at 37&#176;C using an air&#8208;heating system built into the mouse holder. A pneumatic respiratory pillow was placed on the abdomen to monitor respiration throughout imaging and to provide respiratory gating. A three&#8208;dimensional T<sub>1</sub>&#8208;weighted spoiled gradient&#8208;echo sequence was run with the following parameters: repetition time&#8201;=&#8201;11&#8201;ms, echo time&#8201;=&#8201;5&#8201;ms, flip angle&#8201;=&#8201;30&#176;, matrix&#8201;=&#8201;256&#8201;&#215;&#8201;128&#8201;&#215;&#8201;24, field of view&#8201;=&#8201;60&#8201;&#215;&#8201;45&#8201;mm, slice thickness&#8201;=&#8201;1.0&#8201;mm, voxel size&#8201;=&#8201;0.2344&#8201;&#215;&#8201;0.3516&#8201;&#215;&#8201;1.0&#8201;mm<sup>3</sup>, and number of signal averaging&#8201;=&#8201;4. T<sub>1</sub> mapping was performed using a variable flip angle approach<xref rid="mrm30522-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> with a three&#8208;dimensional SPGR sequence: repetition time&#8201;=&#8201;11&#8201;ms, echo time&#8201;=&#8201;5&#8201;ms, flip angle =&#8201;[2&#176;, 3&#176;, 10&#176;, 20&#176;], matrix&#8201;=&#8201;256&#8201;&#215;&#8201;128&#8201;&#215;&#8201;24, field of view&#8201;=&#8201;60&#8201;&#215;&#8201;45&#8201;mm, slice thickness&#8201;=&#8201;1.0&#8201;mm, voxel size&#8201;=&#8201;0.2344&#8201;&#215;&#8201;0.3516&#8201;&#215;&#8201;1.0&#8201;mm<sup>3</sup>, and number of signal averaging&#8201;=&#8201;4.</p></sec><sec id="mrm30522-sec-0011"><label>2.5</label><title>
<styled-content style="fixed-case" toggle="no">MRI</styled-content> data analysis</title><p>Quantitative T<sub>1</sub> data analysis and signal&#8208;to&#8208;noise ratio (SNR) calculations on T<sub>1</sub>&#8208;weighted images were performed in house using <italic toggle="yes">MATLAB</italic> (v2022; MathWorks, Natick, MA, USA). Organs were manually segmented by drawing regions of interest (ROIs) on T<sub>1</sub> maps to circumscribe the relevant organs. T<sub>1</sub> relaxation times were averaged in each ROI to arrive at a mean value. T<sub>1</sub> values for different organs were adjusted with respect to the T<sub>1</sub> in urine, which provided a consistent internal reference for correcting any power gain variation. SNRs on T<sub>1</sub>&#8208;weighted images were determined by dividing the mean signal intensity of the ROI by the standard deviation of the background.</p></sec><sec id="mrm30522-sec-0012"><label>2.6</label><title>Histological assessment</title><p>The heart, liver, kidneys, lungs, and spleen were fixed with 4% paraformaldehyde and sent for paraffin&#8208;embedding and sectioning at STTARR Pathology Core (University Health Network, Toronto, Canada). Sections (4&#8208;&#956;m thick) were stained using hematoxylin and eosin (Newcomer Supply, Middleton, WI, USA) for histological analysis. Whole&#8208;slide scanning at 20<mml:math id="jats-math-1" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mo>&#215;</mml:mo></mml:mrow></mml:mrow></mml:math> brightfield was performed by the Advanced Optical Microscopy Facility at the University Health Network. Slides were reviewed and assessed by a pathologist (M.H.) blinded to the groups (<italic toggle="yes">n</italic>&#8201;=&#8201;3 per group).</p></sec><sec id="mrm30522-sec-0013"><label>2.7</label><title>Statistical analysis</title><p>All data are represented as mean&#8201;&#177;&#8201;standard error of the mean. Analysis of variance was used to compare the difference between the two injection doses and across different time intervals. Post hoc analysis used Tukey's honestly significant difference test. Significance was reported at a <italic toggle="yes">p</italic>&#8208;value of 5%.</p></sec></sec><sec sec-type="results" id="mrm30522-sec-0014"><label>3</label><title>RESULTS</title><sec id="mrm30522-sec-0015"><label>3.1</label><title>Mn biodistribution after subcutaneous injection of <styled-content style="fixed-case" toggle="no">MnCl<sub>2</sub>
</styled-content>
</title><p>To examine Mn biodistribution at different time points, absolute Mn content in mouse tissue collected at 2, 6, and 24&#8201;h following injection was measured by ICP&#8208;AES. For both injection doses, 0.2 and 0.4&#8201;mmol Mn/kg, a single subcutaneous injection of MnCl<sub>2</sub> resulted in increased Mn concentration in all tissues measured, including blood, heart, liver, kidneys, leg skeletal muscle, lungs, and spleen (Figure&#160;<xref rid="mrm30522-fig-0001" ref-type="fig">1, T</xref>able&#160;<xref rid="mrm30522-supitem-0001" ref-type="supplementary-material">S1</xref>). Tissue&#8208;level Mn concentration was lower than the injected dose in all tissues except the liver (at 2 and 6&#8201;h following injection) and kidneys (at 2, 6, and 24&#8201;h following injection), which combined took up most of the administered MnCl<sub>2</sub>.</p><fig position="float" fig-type="FIGURE" id="mrm30522-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Mn distribution in mouse tissue after subcutaneous MnCl<sub>2</sub> injection. Mn concentration in tissue (mmol Mn/ kg tissue) was measured at 2, 6, and 24&#8201;h after a subcutaneous injection of MnCl<sub>2</sub> at a dose of 0.2&#8201;mmol Mn/kg (A) or 0.4&#8201;mmol Mn/kg (B) body weight. Tissues were collected, digested, and analyzed by inductively coupled plasma atomic emission spectroscopy. Data are represented as mean&#8201;&#177;&#8201;standard error of the mean (<italic toggle="yes">n</italic>&#8201;=&#8201;3). *Significant difference from baseline control (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="MRM-94-1227-g002.jpg"/></fig><p>Except for leg skeletal muscle, all tissues experienced peak Mn concentration at 2&#8201;h following injection. In these tissues, Mn concentration decreased by 6&#8201;h and further decreased by 24&#8201;h but remained higher than precontrast baseline levels. However, leg skeletal muscle exhibited an anomalous behavior: Muscle Mn concentration increased gradually with time, peaking at the last observed timepoint of 24&#8201;h following injection.</p></sec><sec id="mrm30522-sec-0016"><label>3.2</label><title>Mn&#8208;induced <styled-content style="fixed-case" toggle="no">T<sub>1</sub>
</styled-content> contrast enhancement on <styled-content style="fixed-case" toggle="no">MRI</styled-content>
</title><p>To investigate T<sub>1</sub> contrast enhancement in mouse organs following MnCl<sub>2</sub> injection, animals were imaged on a 3T MRI scanner using T<sub>1</sub>&#8208;weighted and T<sub>1</sub> mapping sequences. The two doses tested displayed similar trends in Mn&#8208;induced contrast changes. Two hours after injecting 0.2&#8201;mmol/kg MnCl<sub>2</sub>, the liver, kidneys, and heart displayed SNR increases of 11.5&#8201;&#177;&#8201;1.5, 21.9&#8201;&#177;&#8201;3.7, and 6.8&#8201;&#177;&#8201;2.0, respectively, on T<sub>1</sub>&#8208;weighted images, accompanying sharp T<sub>1</sub> reductions measured on T<sub>1</sub> maps (Figure&#160;<xref rid="mrm30522-fig-0002" ref-type="fig">2</xref>). At 2&#8201;h following injection, the heart and liver showed the brightest contrast on T<sub>1</sub>&#8208;weighted MRI (Figure&#160;<xref rid="mrm30522-fig-0002" ref-type="fig">2A</xref>). Consistent with this increased contrast, quantitative analysis showed that T<sub>1</sub> values dramatically decreased in the heart (over 2.5&#215;) and liver (over 5&#215;) at 2&#8201;h following injection, gradually increased thereafter but were still lower than baseline at 24&#8201;h (Figure&#160;<xref rid="mrm30522-fig-0002" ref-type="fig">2B,C</xref>). The kidneys displayed bright contrast on T<sub>1</sub>&#8208;weighted MRI at all time points following injection (data not shown), with T<sub>1</sub> values remaining over 2&#215; lower over the full 24&#8201;h (Figure&#160;<xref rid="mrm30522-fig-0002" ref-type="fig">2B,C</xref>). In leg skeletal muscle, contrast enhancement was not obvious until 24&#8201;h following injection (Figure&#160;<xref rid="mrm30522-fig-0002" ref-type="fig">2A</xref>). Muscle T<sub>1</sub> slightly decreased (&#732;10%) after Mn injection and continued decreasing (1.5&#215;) by 24&#8201;h following injection (Figure&#160;<xref rid="mrm30522-fig-0002" ref-type="fig">2B,C</xref>). Comparison of the two injections doses revealed that 0.4&#8201;mmol/kg Mn extended the window of bright contrast in the heart and liver beyond 2 to 6&#8201;h (Figure&#160;<xref rid="mrm30522-fig-0002" ref-type="fig">2A</xref>). Trends in T<sub>1</sub> contrast enhancement (Figure&#160;<xref rid="mrm30522-fig-0002" ref-type="fig">2</xref>) were consistent with those observed in tissue&#8208;level Mn content (Figure&#160;<xref rid="mrm30522-fig-0001" ref-type="fig">1</xref>): lower T<sub>1</sub> values and brighter signal on T<sub>1</sub>&#8208;weighted MRI arose from higher Mn concentration.</p><fig position="float" fig-type="FIGURE" id="mrm30522-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Mn&#8208;induced T<sub>1</sub> contrast enhancement on MRI at 3&#8201;T. (A) Representative whole&#8208;body T<sub>1</sub>&#8208;weighted spoiled gradient&#8208;echo images and T<sub>1</sub> maps of healthy mice after Mn injection at different time points (2, 6, and 24&#8201;h). Quantitative analysis showing mean T<sub>1</sub>s in mouse organs injected with 0.2&#8201;mmol/kg (B) or 0.4&#8201;mmol Mn/kg (C) body weight. Lower T<sub>1</sub> corresponds to stronger (brighter) signal on T<sub>1</sub>&#8208;weighted MRI. Data are represented as mean&#8201;&#177;&#8201;standard error of the mean (<italic toggle="yes">n</italic>&#8201;=&#8201;3). *Significant difference from baseline control (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="MRM-94-1227-g005.jpg"/></fig></sec><sec id="mrm30522-sec-0017"><label>3.3</label><title>Tissue&#8208;level Mn concentration versus Mn&#8208;induced <styled-content style="fixed-case" toggle="no">T<sub>1</sub>
</styled-content> contrast</title><p>To evaluate the Mn concentration required to generate sufficient T<sub>1</sub> contrast on MRI, we compared the tissue&#8208;level Mn content and Mn&#8208;induced T<sub>1</sub> change in the heart, liver, kidneys, and leg skeletal muscle. Tissue&#8208;level Mn content and T<sub>1</sub> change were significantly higher for an injection dose of 0.4&#8201;mmol/kg compared with 0.2&#8201;mmol/kg in all organs (Figure&#160;<xref rid="mrm30522-fig-0003" ref-type="fig">3</xref>). In the liver, tissue&#8208;level Mn content was significantly higher after exposure to 0.4&#8201;mmol/kg Mn compared with 0.2&#8201;mmol/kg Mn at 2&#8201;h, but a discernible difference in peak T<sub>1</sub> contrast enhancement was absent. The kidney saw sustained significant difference in Mn content at all timepoints but no difference between the two dose levels at any timepoint; likewise, T<sub>1</sub> contrast was not different between the two dose levels. In the heart, either 0.2 or 0.4&#8201;mmol/kg provided a significant T<sub>1</sub> change from baseline at all times but no additional advantage from a higher dose. Uniquely, leg skeletal muscle at 0.2&#8201;mmol/kg of injected Mn required 24&#8201;h following injection to accumulate a significant T<sub>1</sub> change, but the higher dose of 0.4&#8201;mmol/kg shortened the interval to 6&#8201;h following injection. Finally, a linear relationship between R<sub>1</sub> (i.e. 1/T<sub>1</sub>) and Mn concentration was observed in all tissues: leg skeletal muscle (<italic toggle="yes">R</italic>
<sup>2</sup>&#8201;=&#8201;0.93), heart (<italic toggle="yes">R</italic>
<sup>2</sup>&#8201;=&#8201;0.90), kidneys (<italic toggle="yes">R</italic>
<sup>2</sup>&#8201;=&#8201;0.87), and liver (<italic toggle="yes">R</italic>
<sup>2</sup>&#8201;=&#8201;0.94) (Figure&#160;<xref rid="mrm30522-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="mrm30522-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Comparison between tissue&#8208;level absolute Mn content and T<sub>1</sub> contrast enhancement in mouse organs after MnCl<sub>2</sub> injection. Mn content (mmol Mn/kg tissue) measured in the leg skeletal muscle (A), heart (B), kidneys (C), and liver (D). T<sub>1</sub> percentage change from baseline analyzed in the leg skeletal muscle (E), heart (F), kidneys (G), and liver (H). Data are represented as mean&#8201;&#177;&#8201;standard error of the mean (<italic toggle="yes">n</italic>&#8201;=&#8201;3). *Significant difference from baseline (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). <sup>#</sup>Significant difference from corresponding 0.2&#8201;mmol/kg datapoint (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="MRM-94-1227-g004.jpg"/></fig><fig position="float" fig-type="FIGURE" id="mrm30522-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Correlation between R<sub>1</sub> (1/T<sub>1</sub>) and tissue absolute Mn content. Correlation graphs are shown for leg skeletal muscle (A), heart (B), kidneys (C), and liver (D). Data from three time points, two doses, and control were used to generate the correlation figures. Data are represented as mean&#8201;&#177;&#8201;standard error of the mean (<italic toggle="yes">n</italic>&#8201;=&#8201;3).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="MRM-94-1227-g003.jpg"/></fig></sec><sec id="mrm30522-sec-0018"><label>3.4</label><title>Histological assessment</title><p>To evaluate systemic toxicity in mice following a single subcutaneous injection of MnCl<sub>2</sub> at 0.2 and 0.4&#8201;mmol/kg, organs of interest collected at 2&#8201;weeks following Mn injection were stained with hematoxylin and eosin and assessed. In general, histological evaluation of liver, kidneys, lungs, heart, and spleen from Mn&#8208;treated and untreated mice revealed no abnormalities. Representative images showing normal organ structures are displayed in Figure&#160;<xref rid="mrm30522-fig-0005" ref-type="fig">5</xref>. A detailed histopathological report is provided in Table&#160;<xref rid="mrm30522-supitem-0001" ref-type="supplementary-material">S2</xref>. Histopathological findings such as minimal mononuclear cell infiltration in the liver and minimal extramedullary hematopoiesis in the spleen are reported in Table&#160;<xref rid="mrm30522-supitem-0001" ref-type="supplementary-material">S2</xref>; however, these were incidental or spontaneous background lesions commonly noted in mice, which is likely unrelated to Mn injections, as similar observations were also present in the untreated control mice.</p><fig position="float" fig-type="FIGURE" id="mrm30522-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Representative histological analysis of the heart, lung, spleen, kidney, and liver of Mn&#8208;treated and untreated mice displaying normal tissue morphology. Hematoxylin and eosin staining of mouse tissue was collected 2&#8201;weeks after subcutaneous injection of MnCl<sub>2</sub> at 0.2 or 0.4&#8201;mmol/kg (<italic toggle="yes">n</italic>&#8201;=&#8201;3). Mice with no treatment were used for control (<italic toggle="yes">n</italic>&#8201;=&#8201;3). Scale bar&#8201;=&#8201;50&#8201;&#956;m.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="MRM-94-1227-g001.jpg"/></fig></sec></sec><sec sec-type="discussion" id="mrm30522-sec-0019"><label>4</label><title>DISCUSSION</title><p>This study was undertaken with the objective of profiling the time&#8208;course biodistribution and T<sub>1</sub> contrast induced by MnCl<sub>2</sub> administered subcutaneously&#8212;a route that, in our experience, is much safer than intravenous or intraperitoneal. This safer profile is attributed to a slower release of Mn ions to the body, a more sustained whole&#8208;body distribution, and circumventing potentially fatal outcomes from sudden spikes in blood Mn levels associated with intravenous or even intraperitoneal injection. Despite this safer profile, subcutaneous MnCl<sub>2</sub> injection is the least common and its in vivo kinetics the least studied outside of the brain.<xref rid="mrm30522-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="mrm30522-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="mrm30522-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> In this paper, we present, to our best knowledge, new data on the systemic biodistribution of Mn following a single, subcutaneous injection of MnCl<sub>2</sub> in healthy mice. Our findings provide critical information for optimizing Mn injection dose and ideal imaging timepoints for different organs.</p><p>An injection dose of 0.2&#8201;mmol/kg MnCl<sub>2</sub> was sufficient in providing substantial contrast enhancement (60%&#8211;80% decrease in T<sub>1</sub>) in the liver, kidneys, and heart on MRI at 3&#8201;T. Doubling the injection dose to 0.4&#8201;mmol/kg was necessary to achieving T<sub>1</sub> enhancement in skeletal muscle, where the peak T<sub>1</sub> reduction exceeded 50%. For all other tissues, doubling the dose to 0.4&#8201;mmol/kg resulted in negligible further T<sub>1</sub> enhancement despite nearly a doubling in tissue Mn content. The fact that the tissue Mn concentration also increased significantly indicates that the plateau in T<sub>1</sub> enhancement reflects not a physiological limit but a nonlinear relationship between 1/T<sub>1</sub> and Mn concentration at high tissue Mn content. This nonlinear relationship arises from multiple factors, including (i) a saturation in the number water protons available to interact with the Mn ion, (ii) local susceptibility effects where T<sub>2</sub> contrast begins offsetting T<sub>1</sub> enhancement, and possibly (iii) altered T<sub>1</sub> relaxivity due to binding of Mn to proteins. This nonlinear relationship is visible in the graphs of Figure&#160;<xref rid="mrm30522-fig-0004" ref-type="fig">4</xref>, where a slight deviation from linearity emerges above an injection dose of 0.1&#8201;mmol/kg.</p><p>The ideal imaging timepoint was also dependent on the tissue of interest. Most tissues (i.e., heart, liver, and kidneys) reached peak contrast enhancement at 2&#8201;h following injection. Trends in contrast enhancement on MRI corroborated with ICP&#8208;AES quantitation of tissue&#8208;level absolute Mn content. In fact, ICP&#8208;AES measurement of Mn concentration revealed that Mn accumulation peaked also at 2&#8201;h for tissues that were not analyzed on MRI: the lungs, blood, and spleen. Skeletal muscle in the leg was the only tissue that reached peak contrast enhancement and peak tissue&#8208;level Mn content at 24&#8201;h following injection.</p><p>Comparison with existing literature uncovered both concordant results and discrepancies. Concordance was seen in the major organs (i.e., heart, liver, kidneys, and spleen), where literature studies of intravenous MnCl<sub>2</sub> or radiomanganese injection also reported peak Mn content<xref rid="mrm30522-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="mrm30522-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="mrm30522-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> and T<sub>1</sub> contrast enhancement<xref rid="mrm30522-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> within 2&#8201;h following injection. This temporal behavior is consistent <italic toggle="yes">regardless</italic> of the contrast administration route. However, discrepancies were seen in skeletal muscle. Our study showed Mn content in muscle and T<sub>1</sub> contrast peaking at 24&#8201;h following subcutaneous injection. However, literature shows that intravenous injection of radiolabeled <sup>52</sup>Mn resulted in peak tissue Mn concentration at 1&#8201;h,<xref rid="mrm30522-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> and intraperitoneal administration of MnCl<sub>2</sub> (0.1&#8201;mmol/kg) also led to peak T<sub>1</sub> enhancement at 1&#8201;h.<xref rid="mrm30522-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> A different study reported no change in either T<sub>1</sub> enhancement or tissue Mn concentration in muscle 30&#8211;60&#8201;min after intravenous MnCl<sub>2</sub> injection (0.2&#8201;mmol/kg).<xref rid="mrm30522-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> The apparent inconsistency is expected, because low perfusion tissue like skeletal muscle will respond differently to different injection modes. Unlike high perfusion tissue such as the heart, liver, or kidneys, skeletal muscle requires a slower and more sustained injection route to overcome Mn elimination from the body and achieve adequate Mn accumulation.</p><p>With different injection routes possible for administering MnCl<sub>2</sub> for MEMRI, the question remains as to which route to choose for the target organ of interest. If the goal is the maximize contrast in the heart, liver, and kidneys, this study and others have shown that all injection routes (i.e. intravenous, intraperitoneal, and subcutaneous) will work and will maximize contrast enhancement within the first 2&#8201;h following injection.<xref rid="mrm30522-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="mrm30522-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="mrm30522-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> The choice ultimately depends on the operator's comfort level with different injection modes. However, if the goal is to maximize contrast in skeletal muscle, which has relatively very low perfusion, then intravenous or intraperitoneal injection will not confer significant contrast enhancement<xref rid="mrm30522-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="mrm30522-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>&#8212;only the subcutaneous injection route is effective, as seen in this and previous studies.<xref rid="mrm30522-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="mrm30522-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="mrm30522-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>
</p><p>As to why only the subcutaneous injection route was able to generate significant T<sub>1</sub> contrast in skeletal muscle, we need to consider the pharmacokinetics of this administration mode. Injected under the skin on the mouse dorsum, the MnCl<sub>2</sub> solution formed a visible depot that was slowly absorbed into the local blood circulation. Once in circulation, it distributed rapidly to the heart, liver, and kidneys on a time course like those reported for intravenous or intraperitoneal injections. The enhancement profile in liver is particularly interesting; here, we observed a substantial T<sub>1</sub> enhancement that dropped to nearly zero by 24&#8201;h, when other organs still had residual enhancement. This profile can be explained by the fact that MnCl<sub>2</sub> is eliminated primarily by the liver. The initial T<sub>1</sub> enhancement driven by hepatocyte uptake of Mn ions quickly reverses direction as Mn is actively secreted into bile, removed from the liver, and then eliminated in feces. This biliary excretion is extremely efficient and occurs in a matter of hours. Organs that do not have this active Mn elimination mechanism, such as the heart, retained a small but significant level of Mn even at 24&#8201;h following injection. Skeletal muscle exhibited an entirely unique behavior: T<sub>1</sub> enhancement continued past 2&#8201;h following injection and was highest at 24&#8201;h, which is not seen in either intravenous or intraperitoneal contrast administration. Because of this sustained enhancement enabled by subcutaneous contrast injection, adequate signal builds up in muscle by 24&#8201;h. A plausible explanation for the sustained contrast increase may be that because resting skeletal muscle has low perfusion and because the subcutaneous depot slowly releases MnCl<sub>2</sub> into the circulation, there is a constant source of contrast agent that very slowly but steadily distributes in muscle. From Figure&#160;<xref rid="mrm30522-fig-0004" ref-type="fig">4</xref>, we note that Mn content in muscle tissue remains low, on par with that in blood, for quite a long time, thus allowing the sustained transfer of Mn from blood to skeletal muscle without significant backflux. Another possibility for Mn accumulation is that once Mn enters skeletal myocytes, it is sequestered in the numerous mitochondria found in skeletal muscle.</p><p>The potential for Mn&#8208;related toxicity has always been a challenge in MEMRI. It is well known that Mn accumulation in the brain can cause chronic neurodegenerative disease.<xref rid="mrm30522-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Heart arrest can be induced when Mn is abruptly elevated in blood. Therefore, protocols that use intravenous administration must ensure a slow infusion rate. Peak plasma levels can be reduced by adopting intraperitoneal and subcutaneous administration, which have LD50 levels of 0.73&#8201;mmol/kg<xref rid="mrm30522-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> and 1.62&#8201;mmol/kg,<xref rid="mrm30522-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> respectively, in mice. In literature MEMRI studies, a wide range of MnCl<sub>2</sub> injection doses (0.05 to 1.39&#8201;mmol/kg<xref rid="mrm30522-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>) has been tested, with most results reported for intravenous and intraperitoneal injections. For instance, 0.35&#8211;0.70&#8201;mmol/kg (intravenous) is the reported optimal range for imaging the mouse brain,<xref rid="mrm30522-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> and 0.2&#8201;mmol/kg is the saturation point for signal enhancement in the mouse heart (both intravenous and intraperitoneal).<xref rid="mrm30522-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="mrm30522-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> Few reports exist for the subcutaneous route beyond the handful on imaging the mouse brain (0.16&#8201;mmol/kg<xref rid="mrm30522-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> and 1.0&#8201;mmol/kg<xref rid="mrm30522-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>) and tumors in rodents (0.05&#8201;mmol/kg<xref rid="mrm30522-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="mrm30522-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>). To ascertain that the injection doses of 0.2 and 0.4&#8201;mmol/kg used in this study were nontoxic, histology was performed on the heart, liver, kidneys, lungs, and spleen. No abnormalities were observed 2&#8201;weeks following injection.</p><p>Several limitations of this study are noted. Only healthy female mice were investigated, but we expect negligible sex&#8208;related differences in the transport kinetics of Mn ions. Second, contrast kinetics were not probed with more frequent intervals due to the need to reduce repeated exposure to isoflurane over a 24&#8208;h period; future studies can probe contrast kinetics at time intervals that interleave with the ones in the current study. Third, more detailed information on toxicity can be gleaned by assessing metabolic function (e.g., alanine aminotransferase/aspartate aminotransferase test of liver function, creatinine test of kidney function). Finally, the toxicity associated with multiple injections of MnCl<sub>2</sub> was not studied.</p></sec><sec sec-type="conclusions" id="mrm30522-sec-0020"><label>5</label><title>CONCLUSIONS</title><p>In this study, the time&#8208;course biodistribution profile of subcutaneously injected Mn was investigated in vivo in healthy mice. An injection dose of 0.2&#8201;mmol/kg provided substantial contrast enhancement in most organs, such as the heart, liver, and kidneys. Only skeletal muscle required 0.4&#8201;mmol/kg to attain a T<sub>1</sub> reduction exceeding 50%; muscle also exhibited maximal T<sub>1</sub> contrast at 24&#8201;h following injection instead of 2&#8201;h. No toxicity was noted on histology 2&#8201;weeks following a 0.4&#8208;mmol/kg injection of MnCl<sub>2</sub>.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="mrm30522-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S1.</bold> Mn concentrations and T<sub>1</sub> relaxation times in mouse organs after subcutaneous MnCl<sub>2</sub> injection.</p><p>
<bold>Table S2.</bold> Histopathology assessment report of the heart, kidney, liver, lung, and spleen of Mn&#8208;treated and untreated mice.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MRM-94-1227-s001.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="mrm30522-sec-0021"><title>ACKNOWLEDGMENTS</title><p>This work was supported by the Canadian First Research Excellence Fund &#8220;Medicine by Design&#8221; Pivotal Experiment Fund (#MbDPEFR1&#8208;2021&#8208;04 to H.L.M.C.); New Frontiers in Research Fund (#NFRFE&#8208;2020&#8208;00509 to H.L.M.C.); Natural Sciences and Engineering Research Council of Canada (#RGPIN&#8208;2019&#8208;06137 to H.L.M.C.); Canada Foundation for Innovation (#34038 to H.L.M.C.); and Dean's Spark Professorship (to H.L.M.C.). The funding body played no role in the design of the study and collection, analysis, and interpretation of data, nor in writing the manuscript.</p></ack><sec sec-type="data-availability" id="mrm30522-sec-0023"><title>DATA AVAILABILITY STATEMENT</title><p>Data and analysis code are available via the University of Toronto data repository, U of T Dataverse: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fborealisdata.ca%2Fdataset.xhtml%3FpersistentId%3Ddoi%3A10.5683%2FSP3%2FE1QFRN&amp;data=05%7C02%7Chailing.cheng%40utoronto.ca%7Cb4e5a075b02646d6a93108dd671b94fe%7C78aac2262f034b4d9037b46d56c55210%7C0%7C0%7C638780090356502529%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=l5xYYAmo3UM7pbD4RbbNJhH4FdLGJZc1tibyB5maQ5c%3D&amp;reserved=0" ext-link-type="uri" specific-use="software is-supplemented-by">https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fborealisdata.ca%2Fdataset.xhtml%3FpersistentId%3Ddoi%3A10.5683%2FSP3%2FE1QFRN&amp;data=05%7C02%7Chailing.cheng%40utoronto.ca%7Cb4e5a075b02646d6a93108dd671b94fe%7C78aac2262f034b4d9037b46d56c55210%7C0%7C0%7C638780090356502529%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=l5xYYAmo3UM7pbD4RbbNJhH4FdLGJZc1tibyB5maQ5c%3D&amp;reserved=0</ext-link>.</p></sec><ref-list id="mrm30522-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="mrm30522-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="mrm30522-cit-0001"><string-name name-style="western"><surname>Mendon&#231;a&#8208;Dias</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Gaggelli</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Lauterbur</surname><given-names>PC</given-names></string-name>. <article-title>Paramagnetic contrast agents in nuclear magnetic resonance medical imaging</article-title>. <source>Semin Nucl Med.</source><year>1983</year>;<volume>13</volume>:<fpage>364</fpage>&#8208;<lpage>376</lpage>.<pub-id pub-id-type="pmid">6359418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0001-2998(83)80048-8</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="mrm30522-cit-0002"><string-name name-style="western"><surname>Cory</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Schwartzentruber</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Mock</surname><given-names>BH</given-names></string-name>. <article-title>Ingested manganese chloride as a contrast agent for magnetic resonance imaging</article-title>. <source>Magn Reson Imaging.</source><year>1987</year>;<volume>5</volume>:<fpage>65</fpage>&#8208;<lpage>70</lpage>.<pub-id pub-id-type="pmid">3586874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0730-725x(87)90485-1</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0003"><label>3</label><mixed-citation publication-type="book" id="mrm30522-cit-0003"><string-name name-style="western"><surname>Keen</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Ensunsa</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Clegg</surname><given-names>MS</given-names></string-name>. <part-title>Manganese metabolism in animals and humans including the toxicity of manganese</part-title>. <source>Metal Ions in Biological Systems</source>. <publisher-name>CRC Press</publisher-name>; <year>2000</year>.<pub-id pub-id-type="pmid">10693132</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="mrm30522-cit-0004"><string-name name-style="western"><surname>Id&#233;e</surname><given-names>J&#8208;M</given-names></string-name>, <string-name name-style="western"><surname>Port</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Raynal</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Schaefer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>le Greneur</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Corot</surname><given-names>C</given-names></string-name>. <article-title>Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review</article-title>. <source>Fundam Clin Pharmacol.</source><year>2006</year>;<volume>20</volume>:<fpage>563</fpage>&#8208;<lpage>576</lpage>.<pub-id pub-id-type="pmid">17109649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1472-8206.2006.00447.x</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="mrm30522-cit-0005"><string-name name-style="western"><surname>Narita</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kawasaki</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Kita</surname><given-names>H</given-names></string-name>. <article-title>Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs</article-title>. <source>Brain Res.</source><year>1990</year>;<volume>510</volume>:<fpage>289</fpage>&#8208;<lpage>295</lpage>.<pub-id pub-id-type="pmid">2158851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0006-8993(90)91379-u</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="mrm30522-cit-0006"><string-name name-style="western"><surname>Bonilla</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Salazar</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Villasmil</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Villalobos</surname><given-names>R</given-names></string-name>. <article-title>The regional distribution of manganese in the normal human brain</article-title>. <source>Neurochem Res.</source><year>1982</year>;<volume>7</volume>:<fpage>221</fpage>&#8208;<lpage>227</lpage>.<pub-id pub-id-type="pmid">7121709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00965060</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="mrm30522-cit-0007"><string-name name-style="western"><surname>Natt</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Watanabe</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Boretius</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Radulovic</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Frahm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Michaelis</surname><given-names>T</given-names></string-name>. <article-title>High&#8208;resolution 3D MRI of mouse brain reveals small cerebral structures in vivo</article-title>. <source>J Neurosci Methods.</source><year>2002</year>;<volume>120</volume>:<fpage>203</fpage>&#8208;<lpage>209</lpage>.<pub-id pub-id-type="pmid">12385770</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0165-0270(02)00211-x</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="mrm30522-cit-0008"><string-name name-style="western"><surname>Lin</surname><given-names>Y&#8208;J</given-names></string-name>, <string-name name-style="western"><surname>Koretsky</surname><given-names>AP</given-names></string-name>. <article-title>Manganese ion enhances T<sub>1</sub>&#8208;weighted MRI during brain activation: an approach to direct imaging of brain function</article-title>. <source>Magn Reson Med.</source><year>1997</year>;<volume>38</volume>:<fpage>378</fpage>&#8208;<lpage>388</lpage>.<pub-id pub-id-type="pmid">9339438</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mrm.1910380305</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="mrm30522-cit-0009"><string-name name-style="western"><surname>Pautler</surname><given-names>RG</given-names></string-name>, <string-name name-style="western"><surname>Silva</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Koretsky</surname><given-names>AP</given-names></string-name>. <article-title>In vivo neuronal tract tracing using manganese&#8208;enhanced magnetic resonance imaging</article-title>. <source>Magn Reson Med.</source><year>1998</year>;<volume>40</volume>:<fpage>740</fpage>&#8208;<lpage>748</lpage>.<pub-id pub-id-type="pmid">9797158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mrm.1910400515</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="mrm30522-cit-0010"><string-name name-style="western"><surname>Hunter</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Haworth</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Berkoff</surname><given-names>HA</given-names></string-name>. <article-title>Cellular manganese uptake by the isolated perfused rat heart: a probe for the sarcolemma calcium channel</article-title>. <source>J Mol Cell Cardiol.</source><year>1981</year>;<volume>13</volume>:<fpage>823</fpage>&#8208;<lpage>832</lpage>.<pub-id pub-id-type="pmid">6271977</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0022-2828(81)90239-x</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="mrm30522-cit-0011"><string-name name-style="western"><surname>Hu</surname><given-names>TC&#8208;C</given-names></string-name>, <string-name name-style="western"><surname>Bao</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Lenhard</surname><given-names>SC</given-names></string-name>, et al. <article-title>Simultaneous assessment of left&#8208;ventricular infarction size, function and tissue viability in a murine model of myocardial infarction by cardiac manganese&#8208;enhanced magnetic resonance imaging (MEMRI)</article-title>. <source>NMR Biomed</source>. <year>2004</year>;<volume>17</volume>:<fpage>620</fpage>&#8208;<lpage>626</lpage>.<pub-id pub-id-type="pmid">15761951</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nbm.933</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="mrm30522-cit-0012"><string-name name-style="western"><surname>Suero&#8208;Abreu</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Praveen Raju</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Aristiz&#225;bal</surname><given-names>O</given-names></string-name>, et al. <article-title>
<italic toggle="yes">In vivo</italic> Mn&#8208;enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model</article-title>. <source>Neoplasia.</source><year>2014</year>;<volume>16</volume>:<fpage>993</fpage>&#8208;<lpage>1006</lpage>.<pub-id pub-id-type="pmid">25499213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neo.2014.10.001</pub-id><pub-id pub-id-type="pmcid">PMC4309249</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="mrm30522-cit-0013"><string-name name-style="western"><surname>Nofiele</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Czarnota</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>H&#8208;LM</given-names></string-name>. <article-title>Noninvasive manganese&#8208;enhanced magnetic resonance imaging for early detection of breast cancer metastatic potential</article-title>. <source>Mol Imaging.</source><year>2014</year>;<volume>13</volume>. doi:<pub-id pub-id-type="doi">10.2310/7290.2013.00071</pub-id><pub-id pub-id-type="pmid">24622809</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="mrm30522-cit-0014"><string-name name-style="western"><surname>Ganesh</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Mokhtari</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Alhamami</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yeger</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>H&#8208;LM</given-names></string-name>. <article-title>Manganese&#8208;enhanced MRI of minimally gadolinium&#8208;enhancing breast tumors</article-title>. <source>J Magn Reson Imaging.</source><year>2015</year>;<volume>41</volume>:<fpage>806</fpage>&#8208;<lpage>813</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jmri.24608</pub-id><pub-id pub-id-type="pmid">24591227</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="mrm30522-cit-0015"><string-name name-style="western"><surname>Prevarskaya</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Skryma</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Shuba</surname><given-names>Y</given-names></string-name>. <article-title>Calcium in tumour metastasis: new roles for known actors</article-title>. <source>Nat Rev Cancer.</source><year>2011</year>;<volume>11</volume>:<fpage>609</fpage>&#8208;<lpage>618</lpage>.<pub-id pub-id-type="pmid">21779011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrc3105</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="mrm30522-cit-0016"><string-name name-style="western"><surname>Zhuang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Romagnuolo</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sadikov Valdman</surname><given-names>T</given-names></string-name>, et al. <article-title>Bright ferritin for long&#8208;term MR imaging of human embryonic stem cells</article-title>. <source>Stem Cell Res Ther.</source><year>2023</year>;<volume>14</volume>:<fpage>330</fpage>.<pub-id pub-id-type="pmid">37964388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13287-023-03565-4</pub-id><pub-id pub-id-type="pmcid">PMC10647036</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="mrm30522-cit-0017"><string-name name-style="western"><surname>Luo</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhuang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>SJ</given-names></string-name>, et al. <article-title>Longitudinal magnetic resonance imaging tracking of transplanted neural progenitor cells in the spinal cord utilizing the bright&#8208;ferritin mechanism</article-title>. <source>Stem Cells Transl Med.</source><year>2024</year>;<volume>13</volume>:<fpage>546</fpage>&#8208;<lpage>558</lpage>.<pub-id pub-id-type="pmid">38457239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/stcltm/szae016</pub-id><pub-id pub-id-type="pmcid">PMC11165155</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="mrm30522-cit-0018"><string-name name-style="western"><surname>Cersosimo</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Koller</surname><given-names>WC</given-names></string-name>. <article-title>The diagnosis of manganese&#8208;induced parkinsonism</article-title>. <source>Neurotoxicology.</source><year>2006</year>;<volume>27</volume>:<fpage>340</fpage>&#8208;<lpage>346</lpage>.<pub-id pub-id-type="pmid">16325915</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuro.2005.10.006</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="mrm30522-cit-0019"><string-name name-style="western"><surname>O'Neal</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>W</given-names></string-name>. <article-title>Manganese toxicity upon overexposure: a decade in review</article-title>. <source>Curr Environ Health Rep.</source><year>2015</year>;<volume>2</volume>:<fpage>315</fpage>&#8208;<lpage>328</lpage>.<pub-id pub-id-type="pmid">26231508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40572-015-0056-x</pub-id><pub-id pub-id-type="pmcid">PMC4545267</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="mrm30522-cit-0020"><string-name name-style="western"><surname>Silva</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Aoki</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Koretsky</surname><given-names>AP</given-names></string-name>. <article-title>Manganese&#8208;enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations</article-title>. <source>NMR Biomed.</source><year>2004</year>;<volume>17</volume>:<fpage>532</fpage>&#8208;<lpage>543</lpage>.<pub-id pub-id-type="pmid">15617052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nbm.945</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="mrm30522-cit-0021"><string-name name-style="western"><surname>Sotogaku</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Oku</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Takeda</surname><given-names>A</given-names></string-name>. <article-title>Manganese concentration in mouse brain after intravenous injection</article-title>. <source>J Neurosci Res.</source><year>2000</year>;<volume>61</volume>:<fpage>350</fpage>&#8208;<lpage>356</lpage>.<pub-id pub-id-type="pmid">10900082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-4547(20000801)61:3&lt;350::AID-JNR13&gt;3.0.CO;2-4</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="mrm30522-cit-0022"><string-name name-style="western"><surname>Watanabe</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Natt</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Boretius</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Frahm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Michaelis</surname><given-names>T</given-names></string-name>. <article-title>In vivo 3D MRI staining of mouse brain after subcutaneous application of MnCl2</article-title>. <source>Magn Reson Med.</source><year>2002</year>;<volume>48</volume>:<fpage>852</fpage>&#8208;<lpage>859</lpage>.<pub-id pub-id-type="pmid">12418000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mrm.10276</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="mrm30522-cit-0023"><string-name name-style="western"><surname>Kuo</surname><given-names>Y&#8208;T</given-names></string-name>, <string-name name-style="western"><surname>Herlihy</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>So</surname><given-names>P&#8208;W</given-names></string-name>, <string-name name-style="western"><surname>Bhakoo</surname><given-names>KK</given-names></string-name>, <string-name name-style="western"><surname>Bell</surname><given-names>JD</given-names></string-name>. <article-title>In vivo measurements of T<sub>1</sub> relaxation times in mouse brain associated with different modes of systemic administration of manganese chloride</article-title>. <source>J Magn Reson Imaging.</source><year>2005</year>;<volume>21</volume>:<fpage>334</fpage>&#8208;<lpage>339</lpage>.<pub-id pub-id-type="pmid">15779025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmri.20285</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="mrm30522-cit-0024"><string-name name-style="western"><surname>Lee</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Silva</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Merkle</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Koretsky</surname><given-names>AP</given-names></string-name>. <article-title>Manganese&#8208;enhanced magnetic resonance imaging of mouse brain after systemic administration of MnCl2: dose&#8208;dependent and temporal evolution of T<sub>1</sub> contrast</article-title>. <source>Magn Reson Med.</source><year>2005</year>;<volume>53</volume>:<fpage>640</fpage>&#8208;<lpage>648</lpage>.<pub-id pub-id-type="pmid">15723400</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mrm.20368</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="mrm30522-cit-0025"><string-name name-style="western"><surname>Tanihira</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Fujiwara</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kikuta</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Homma</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Osanai</surname><given-names>M</given-names></string-name>. <article-title>Manganese dynamics in mouse brain after systemic MnCl<sub>2</sub> administration for activation&#8208;induced manganese&#8208;enhanced MRI</article-title>. <source>Front Neural Circuit.</source><year>2021</year>;<volume>15</volume>:<fpage>1</fpage>&#8208;<lpage>12</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fncir.2021.787692</pub-id><pub-id pub-id-type="pmcid">PMC8722453</pub-id><pub-id pub-id-type="pmid">34987361</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="mrm30522-cit-0026"><string-name name-style="western"><surname>Shazeeb</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Sotak</surname><given-names>CH</given-names></string-name>. <article-title>Dose dependence and temporal evolution of the T<sub>1</sub> relaxation time and MRI contrast in the rat brain after subcutaneous injection of manganese chloride</article-title>. <source>Magn Reson Med.</source><year>2012</year>;<volume>68</volume>:<fpage>1955</fpage>&#8208;<lpage>1962</lpage>.<pub-id pub-id-type="pmid">22294279</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mrm.24184</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="mrm30522-cit-0027"><string-name name-style="western"><surname>Takeda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sawashita</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Okada</surname><given-names>S</given-names></string-name>. <article-title>Manganese concentration in rat brain: manganese transport from the peripheral tissues</article-title>. <source>Neurosci Lett.</source><year>1998</year>;<volume>242</volume>:<fpage>45</fpage>&#8208;<lpage>48</lpage>.<pub-id pub-id-type="pmid">9510001</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0304-3940(98)00006-8</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="mrm30522-cit-0028"><string-name name-style="western"><surname>Sep&#250;lveda</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Dresselaers</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Vangheluwe</surname><given-names>P</given-names></string-name>, et al. <article-title>Evaluation of manganese uptake and toxicity in mouse brain during continuous MnCl<sub>2</sub> administration using osmotic pumps</article-title>. <source>Contrast Media Mol Imaging.</source><year>2012</year>;<volume>7</volume>:<fpage>426</fpage>&#8208;<lpage>434</lpage>.<pub-id pub-id-type="pmid">22649049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cmmi.1469</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="mrm30522-cit-0029"><string-name name-style="western"><surname>Schroeder</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Weiss</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Procissi</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Disterhoft</surname><given-names>JF</given-names></string-name>. <article-title>Activity&#8208;induced manganese&#8208;dependent MRI (AIM&#8208;MRI) and functional MRI in awake rabbits during somatosensory stimulation</article-title>. <source>Neuroimage.</source><year>2016</year>;<volume>126</volume>:<fpage>72</fpage>&#8208;<lpage>80</lpage>.<pub-id pub-id-type="pmid">26589332</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2015.11.033</pub-id><pub-id pub-id-type="pmcid">PMC4733628</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="mrm30522-cit-0030"><string-name name-style="western"><surname>Waghorn</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chuang</surname><given-names>K&#8208;H</given-names></string-name>, <string-name name-style="western"><surname>Yanasak</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>TC&#8208;C</given-names></string-name>. <article-title>Monitoring dynamic alterations in calcium homeostasis by T 1&#8208;weighted and T<sub>1</sub>&#8208;mapping cardiac manganese&#8208;enhanced MRI in a murine myocardial infarction model</article-title>. <source>NMR Biomed</source>. <year>2008</year>;<volume>21</volume>:<fpage>1102</fpage>&#8208;<lpage>1111</lpage>. doi:<pub-id pub-id-type="doi">10.1002/nbm.1287</pub-id><pub-id pub-id-type="pmid">18780285</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="mrm30522-cit-0031"><string-name name-style="western"><surname>Delattre</surname><given-names>BMA</given-names></string-name>, <string-name name-style="western"><surname>Braunersreuther</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Hyacinthe</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Crowe</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Mach</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Vall&#233;e</surname><given-names>JP</given-names></string-name>. <article-title>Myocardial infarction quantification with manganese&#8208;enhanced MRI (MEMRI) in mice using a 3T clinical scanner</article-title>. <source>NMR Biomed.</source><year>2010</year>;<volume>23</volume>:<fpage>503</fpage>&#8208;<lpage>513</lpage>.<pub-id pub-id-type="pmid">20175138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nbm.1489</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="mrm30522-cit-0032"><string-name name-style="western"><surname>Jasmin</surname><given-names>NH</given-names></string-name>, <string-name name-style="western"><surname>Thin</surname><given-names>MZ</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>RD</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>LH</given-names></string-name>, et al. <article-title>Myocardial viability imaging using manganese&#8208;enhanced MRI in the first hours after myocardial infarction</article-title>. <source>Adv Sci.</source><year>2021</year>;<volume>8</volume>:<elocation-id>2003987</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/advs.202003987</pub-id><pub-id pub-id-type="pmcid">PMC8188227</pub-id><pub-id pub-id-type="pmid">34105284</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="mrm30522-cit-0033"><string-name name-style="western"><surname>Wolf</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Baum</surname><given-names>L</given-names></string-name>. <article-title>Cardiovascular toxicity and tissue proton T<sub>1</sub> response to manganese injection in the dog and rabbit</article-title>. <source>Am J Roentgenol.</source><year>1983</year>;<volume>141</volume>:<fpage>193</fpage>&#8208;<lpage>197</lpage>.<pub-id pub-id-type="pmid">6305179</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2214/ajr.141.1.193</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="mrm30522-cit-0034"><string-name name-style="western"><surname>Ni</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Petr&#233;</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bosmans</surname><given-names>H</given-names></string-name>, et al. <article-title>Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2</article-title>. <source>Acta Radiol.</source><year>1997</year>;<volume>38</volume>:<fpage>700</fpage>&#8208;<lpage>707</lpage>.<pub-id pub-id-type="pmid">9245965</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/02841859709172402</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="mrm30522-cit-0035"><string-name name-style="western"><surname>Lee</surname><given-names>L&#8208;W</given-names></string-name>, <string-name name-style="western"><surname>So</surname><given-names>PW</given-names></string-name>, <string-name name-style="western"><surname>Price</surname><given-names>AN</given-names></string-name>, et al. <article-title>Manganese enhancement in non&#8208;CNS organs</article-title>. <source>NMR Biomed.</source><year>2010</year>;<volume>23</volume>:<fpage>931</fpage>&#8208;<lpage>938</lpage>.<pub-id pub-id-type="pmid">20878971</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nbm.1513</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="mrm30522-cit-0036"><string-name name-style="western"><surname>Missy</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lanhers</surname><given-names>M&#8208;C</given-names></string-name>, <string-name name-style="western"><surname>Cunat</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Joyeux</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Burnel</surname><given-names>D</given-names></string-name>. <article-title>Effects of subchronic exposure to manganese chloride on tissue distribution of three essential elements in rats</article-title>. <source>Int J Toxicol.</source><year>2000</year>;<volume>19</volume>:<fpage>313</fpage>&#8208;<lpage>321</lpage>.</mixed-citation></ref><ref id="mrm30522-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="mrm30522-cit-0037"><string-name name-style="western"><surname>Cheng</surname><given-names>H&#8208;LM</given-names></string-name>, <string-name name-style="western"><surname>Wright</surname><given-names>GA</given-names></string-name>. <article-title>Rapid high&#8208;resolution T<sub>1</sub> mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity</article-title>. <source>Magn Reson Med.</source><year>2006</year>;<volume>55</volume>:<fpage>566</fpage>&#8208;<lpage>574</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mrm.20791</pub-id><pub-id pub-id-type="pmid">16450365</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="mrm30522-cit-0038"><string-name name-style="western"><surname>Wooten</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Aweda</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Lewis</surname><given-names>BC</given-names></string-name>, <string-name name-style="western"><surname>Gross</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Lapi</surname><given-names>SE</given-names></string-name>. <article-title>Biodistribution and PET imaging of pharmacokinetics of manganese in mice using Manganese&#8208;52</article-title>. <source>PLoS One.</source><year>2017</year>;<volume>12</volume>:<elocation-id>e0174351</elocation-id>.<pub-id pub-id-type="pmid">28306727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0174351</pub-id><pub-id pub-id-type="pmcid">PMC5357058</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="mrm30522-cit-0039"><string-name name-style="western"><surname>Szulc</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>XA</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>H&#8208;YM</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>H&#8208;LM</given-names></string-name>. <article-title>Bright ferritin&#8212;a reporter gene platform for on&#8208;demand, longitudinal cell tracking on MRI</article-title>. <source>iScience.</source><year>2020</year>;<volume>23</volume>:<elocation-id>101350</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.isci.2020.101350</pub-id><pub-id pub-id-type="pmid">32707432</pub-id><pub-id pub-id-type="pmcid">PMC7381694</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="mrm30522-cit-0040"><string-name name-style="western"><surname>Williams</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Hoeschele</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>JE</given-names></string-name>, et al. <article-title>Chemical softness and acute metal toxicity in mice and <italic toggle="yes">drosophila</italic>
</article-title>. <source>Toxicol Appl Pharmacol.</source><year>1982</year>;<volume>63</volume>:<fpage>461</fpage>&#8208;<lpage>469</lpage>.<pub-id pub-id-type="pmid">6808706</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0041-008x(82)90274-5</pub-id></mixed-citation></ref><ref id="mrm30522-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="mrm30522-cit-0041"><string-name name-style="western"><surname>S&#225;nchez</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Domingo</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Llobet</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Keen</surname><given-names>CL</given-names></string-name>. <article-title>Maternal and developmental toxicity of manganese in the mouse</article-title>. <source>Toxicol Lett.</source><year>1993</year>;<volume>69</volume>:<fpage>45</fpage>&#8208;<lpage>52</lpage>.<pub-id pub-id-type="pmid">8356567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-4274(93)90144-m</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>